Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/50352COMPARTIR / EXPORTAR:
 SHARE
 CORE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Título: | MYC in chronic myeloid leukemia: Induction of aberrant DNA synthesis and association with poor response to imatinib |
Autor: | Albajar, Marta CSIC; Gómez-Casares, M. Teresa; Mauleon, Itaso; Vaqué, José P. CSIC ORCID; Acosta, Juan C. CSIC ORCID; Delgado, M. Dolores CSIC ORCID; León, Javier CSIC ORCID CVN | Fecha de publicación: | 2011 | Editor: | American Association for Cancer Research | Citación: | Molecular Cancer Research 9(5): 564-576 (2011) | Resumen: | Untreated chronic myeloid leukemia (CML) progresses from chronic phase to blastic crisis (BC). Increased genomic instability, deregulated proliferation, and loss of differentiation appear associated to BC, but the molecular alterations underlying the progression of CML are poorly characterized. MYC oncogene is frequently deregulated in human cancer, often associated with tumor progression. Genomic instability and induction of aberrant DNA replication are described as effects of MYC. In this report, we studied MYC activities in CML cell lines with conditional MYC expression with and without exposure to imatinib, the front-line drug in CML therapy. In cells with conditional MYC expression, MYC did not rescue the proliferation arrest mediated by imatinib but provoked aberrant DNA synthesis and accumulation of cells with 4C content. We studied MYC mRNA expression in 66 CML patients at different phases of the disease, and we found that MYC expression was higher in CML patients at diagnosis than control bone marrows or in patients responding to imatinib. Further, high MYC levels at diagnosis correlated with a poor response to imatinib. MYC expression did not directly correlate with BCR-ABL levels in patients treated with imatinib. Overall our study suggests that, as in other tumor models, MYC-induced aberrant DNA synthesis in CML cells is consistent with MYC overexpression in untreated CML patients and nonresponding patients and supports a role for MYC in CML progression, possibly through promotion of genomic instability. ©2011 AACR. | Descripción: | El pdf es la versión post-print.-- et al. | URI: | http://hdl.handle.net/10261/50352 | DOI: | 10.1158/1541-7786.MCR-10-0356 | Identificadores: | doi: 10.1158/1541-7786.MCR-10-0356 issn: 1541-7786 |
| Aparece en las colecciones: | (IBBTEC) Artículos |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| MYC in chronic.pdf | 584,21 kB | Adobe PDF |  Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
50
checked on 21-abr-2024
WEB OF SCIENCETM
Citations
52
checked on 25-feb-2024
Page view(s)
344
checked on 24-abr-2024
Download(s)
343
checked on 24-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.